Bronchoscopy With Bronchial Biopsies Sub-study of: Persistence of Airway Inflammation and Remodeling in Asthma Remission
Bronchoscopy and Bronchial Biopsies. Sub-study of: Characteristics of Asthma Remissions
This study aims at determining the patterns of asthma remission, the prevalence of these different patterns and the various factors associated with such remissions and possible recurrences of asthma, in order to determine the mechanisms involved in these processes.
We therefore want to document these specificities in studying biopsies of subjects in complete remission of their asthma and those in only symptomatic remission of their asthma, in comparison with mildly symptomatic asthmatic subjects and healthy controls.
연구 개요
상태
정황
상세 설명
Primary Outcome Measures :
Airway inflammation and remodeling: in bronchial biopsies
Secondary Outcome Measures:
Comparisons of bronchial biopsy features between groups:
- Bronchial epithelial morphology
- Bronchial mucosa (smooth muscle, reticular basement membrane, submucosal gland,...)
연구 유형
등록 (예상)
연락처 및 위치
연구 장소
-
-
Quebec
-
Québec, Quebec, 캐나다, G1V 4G5
- Centre de Recherche, Hôpital Laval
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- In remission of their asthma: absence of respiratory symptoms, no rescue asthma medication need and (for complete remission) an optimal pulmonary function (FEV1 > 90%) and normal PC20 methacholine for more than two years (with no current treatment).
- With a proven past history of asthma from medical files (reversible airway obstruction (> 12% FEV1 after bronchodilator or 20% by other means) proven by spirometry, PEF measures or methacholine challenge according to current criteria + previous symptoms and asthma medication use), having no more asthma symptoms and not having used asthma medication for more than 2 years.
- Agree to sign the consent form.
- No other condition that could interfere with the study measurements.
Exclusion Criteria:
- Subjects using inhaled or oral anti-inflammatory agents.
- FEV1 < 1.2 L.
- Unable to adhere to the protocol requirements.
- Other current respiratory disease
- Upper or lower respiratory tract infection or use of antibiotics < 1 month.
- Use of oral corticosteroids within the last 3 months.
- Signs or symptoms of progressive or uncontrolled renal, hepatic, hematologic, endocrine, pulmonary, cardiac, neurologic or cerebral disease.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
|---|
|
4
건강한 통제
|
|
1
Subjects with complete remission of asthma
|
|
2
Subjects with symptomatic remission of asthma
|
|
3
Subjects with asthma
|
공동 작업자 및 조사자
스폰서
수사관
- 수석 연구원: Louis-Philippe Boulat, MD, Hôpital Laval
연구 기록 날짜
연구 주요 날짜
연구 시작
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .